JP2013530208A5 - - Google Patents

Download PDF

Info

Publication number
JP2013530208A5
JP2013530208A5 JP2013517583A JP2013517583A JP2013530208A5 JP 2013530208 A5 JP2013530208 A5 JP 2013530208A5 JP 2013517583 A JP2013517583 A JP 2013517583A JP 2013517583 A JP2013517583 A JP 2013517583A JP 2013530208 A5 JP2013530208 A5 JP 2013530208A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
topical administration
administration
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013517583A
Other languages
English (en)
Japanese (ja)
Other versions
JP5858994B2 (ja
JP2013530208A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2011/001919 external-priority patent/WO2012004669A1/en
Publication of JP2013530208A publication Critical patent/JP2013530208A/ja
Publication of JP2013530208A5 publication Critical patent/JP2013530208A5/ja
Application granted granted Critical
Publication of JP5858994B2 publication Critical patent/JP5858994B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013517583A 2010-07-08 2011-07-08 口唇ヘルペス、性器ヘルペス、および帯状疱疹の再発を抑制するためのポリエチレングリコール組成物 Active JP5858994B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36232910P 2010-07-08 2010-07-08
US61/362,329 2010-07-08
PCT/IB2011/001919 WO2012004669A1 (en) 2010-07-08 2011-07-08 Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Publications (3)

Publication Number Publication Date
JP2013530208A JP2013530208A (ja) 2013-07-25
JP2013530208A5 true JP2013530208A5 (enExample) 2014-07-31
JP5858994B2 JP5858994B2 (ja) 2016-02-10

Family

ID=44588123

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013517583A Active JP5858994B2 (ja) 2010-07-08 2011-07-08 口唇ヘルペス、性器ヘルペス、および帯状疱疹の再発を抑制するためのポリエチレングリコール組成物

Country Status (20)

Country Link
US (2) US9814743B2 (enExample)
EP (1) EP2563374B1 (enExample)
JP (1) JP5858994B2 (enExample)
KR (1) KR101881175B1 (enExample)
CN (1) CN103079574B (enExample)
AU (1) AU2011275458B2 (enExample)
CA (1) CA2803228C (enExample)
DK (1) DK2563374T3 (enExample)
ES (1) ES2442928T3 (enExample)
HR (1) HRP20140135T1 (enExample)
IL (1) IL223582A (enExample)
MX (1) MX2012014783A (enExample)
PL (1) PL2563374T3 (enExample)
PT (1) PT2563374E (enExample)
RS (1) RS53162B (enExample)
RU (1) RU2643763C2 (enExample)
SG (1) SG186937A1 (enExample)
SI (1) SI2563374T1 (enExample)
WO (1) WO2012004669A1 (enExample)
ZA (1) ZA201300177B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101881175B1 (ko) 2010-07-08 2018-07-23 데비렉스 아게 구순포진, 음부포진, 및 대상포진의 재발을 조절하기 위한 폴리에틸렌 글리콜 조성물
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
US9084740B2 (en) 2013-02-19 2015-07-21 Johnson & Johnson Consumer Companies, Inc. Methods and compositions for improving appearance and formation of scar tissue
EP2803354B1 (de) * 2013-05-14 2015-03-04 NajöPharm GmbH i.G. Kombination aus Polyacrylsäure und 2-Amino-2-methylpropanol zur Verwendung in der Behandlung von Herpesinfektionen
UY37497A (es) * 2016-11-28 2018-06-29 Aicuris Anti Infective Cures Gmbh Formulación tópica que comprende n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida
EP3962924A1 (en) 2019-05-03 2022-03-09 Genentech, Inc. Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform
US20210330700A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols
WO2021233571A1 (de) * 2020-04-30 2021-11-25 Ninoderm Ug (Haftungsbeschränkt) Behandlungsmittel zur antiviralen therapie, applikator und verfahren zur herstellung eines behandlungsmittels

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603122A (en) 1979-08-17 1986-07-29 Blough Herbert A Antiviral agent against herpes virus infections
GB2080682B (en) 1980-07-30 1984-03-28 Ciba Geigy Ag Antiherpetically active lipstick
EP0087161A3 (en) 1982-02-24 1984-04-04 Key Pharmaceuticals, Inc. Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament
US5232700A (en) * 1990-11-14 1993-08-03 The Administrators Of The Tulane Educational Fund Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient
NL9500216A (nl) 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
US6045823A (en) * 1996-09-19 2000-04-04 Dragoco Gerberding & Co. Ag Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same
GB9902227D0 (en) * 1999-02-01 1999-03-24 Cipla Limited Pharmaceutical composition for topical administration
US8030260B2 (en) * 2005-03-25 2011-10-04 Chemsil Silicones, Inc Pre-shave compositions and methods of using same
DE202005007363U1 (de) 2005-05-04 2005-07-14 Anton Hübner GmbH & Co. KG Gegen Herpesbläschen verwendbare Kieselsäurezusammensetzungen
RU2009127890A (ru) 2007-01-17 2011-02-27 Девирэкс Аг (Ch) Составы, содержащие циклодекстрины
KR101881175B1 (ko) 2010-07-08 2018-07-23 데비렉스 아게 구순포진, 음부포진, 및 대상포진의 재발을 조절하기 위한 폴리에틸렌 글리콜 조성물
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Similar Documents

Publication Publication Date Title
JP2013530208A5 (enExample)
JP2016538271A5 (enExample)
JP2009286795A5 (enExample)
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
EP4316488A3 (en) Methods and compositions for treatment of attention deficit disorder
WO2013101897A3 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
JP2014530874A5 (enExample)
HK1203514A1 (en) D-amino acid compounds for liver disease
HK1215934A1 (zh) 肽治疗剂及其使用方法
EA201170018A1 (ru) Разагилин для изменения течения болезни паркинсона
JP2014526559A5 (enExample)
JP2012517478A5 (enExample)
HK1206246A1 (en) Use of high dose laquinimod for treating multiple sclerosis
JP2009542581A5 (enExample)
JP2013541583A5 (enExample)
UA111599C2 (uk) Композиція каспофунгіну
HRP20191723T1 (hr) Nukleotid dims0-150 za primjenu u liječenju kroničnog aktivnog ulceroznog kolitisa
JP2014532722A5 (enExample)
RU2013100383A (ru) Композиции полиэтиленгликоля для контроля рецидивов лабиального герпеса, генитального герпеса и опоясывающего герпеса
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
JP2015507020A5 (enExample)
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
JP2007119497A5 (enExample)
EP2575456A4 (en) COMPOSITIONS AND METHODS FOR TREATING PRESENTATIONS
JP2013540734A5 (enExample)